NCT06983171View on ClinicalTrials.gov

Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practice

RecruitingOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

April 2, 2025

Primary Completion Date

September 12, 2028

Study Completion Date

September 12, 2028

Conditions

MAFLD

Trial Locations (1)

125008

RECRUITING

Center of Target Therapy LLC., Moscow

All Listed Sponsors

lead

Center of target therapy

OTHER